Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
Disc Medicine, Inc
National Institutes of Health Clinical Center (CC)
Centre Hospitalier Universitaire de Nice
Virtual Tribunal Monastery
Washington University School of Medicine
George Washington University
Peking University People's Hospital
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Incyte Corporation
Fudan University
Assiut University
Celgene
Indiana University
Weill Medical College of Cornell University
Kazakh Institute of Oncology and Radiology
Thomas Jefferson University
AHS Cancer Control Alberta
University of Chile
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Utah
Mario Negri Institute for Pharmacological Research
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Ottawa Hospital Research Institute
Merck Sharp & Dohme LLC
Institut du Cancer de Montpellier - Val d'Aurelle
Assistance Publique - Hôpitaux de Paris
Fudan University
National Cancer Institute (NCI)
Ontario Clinical Oncology Group (OCOG)
OHSU Knight Cancer Institute
Hospital Universitari Vall d'Hebron Research Institute
M.D. Anderson Cancer Center
Bellicum Pharmaceuticals
Merck Sharp & Dohme LLC
Celgene
OHSU Knight Cancer Institute
University Hospital, Brest
Cairo University
Sun Yat-sen University
Eastern Cooperative Oncology Group
TidalSense
Eurasian Association of Therapists
Blau Farmaceutica S.A.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Merck Sharp & Dohme LLC
Azienda Ospedaliera Universitaria Integrata Verona